Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
14.93
-0.05 (-0.33%)
At close: Aug 13, 2025, 4:00 PM
14.64
-0.29 (-1.94%)
Pre-market: Aug 14, 2025, 9:23 AM EDT
Oscar Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Premiums & Annuity Revenue | 10,513 | 8,971 | 5,686 | 3,871 | 1,886 | 383.22 | Upgrade
|
| Total Interest & Dividend Income | 192.86 | 185.73 | 155.45 | 27.59 | 2.3 | 7.77 | Upgrade
|
| Other Revenue | 20.54 | 20.58 | 21.35 | 64.93 | 5.39 | - | Upgrade
|
| Total Revenue | 10,726 | 9,178 | 5,863 | 3,964 | 1,894 | 390.99 | Upgrade
|
| Revenue Growth (YoY) | 48.29% | 56.54% | 47.92% | 109.27% | 384.43% | -17.79% | Upgrade
|
| Policy Benefits | 8,882 | 7,333 | 4,642 | 3,281 | 1,624 | 309.35 | Upgrade
|
| Depreciation & Amortization | 30.43 | 32.15 | 30.69 | 15.28 | - | - | Upgrade
|
| Selling, General & Administrative | 1,943 | 1,756 | 1,379 | 1,257 | 360.16 | 249.79 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 368.07 | 216.53 | Upgrade
|
| Total Operating Expenses | 10,856 | 9,120 | 6,052 | 4,554 | 2,439 | 793.25 | Upgrade
|
| Operating Income | -129.47 | 57.27 | -189.32 | -589.87 | -544.48 | -402.27 | Upgrade
|
| Interest Expense | -23.68 | -23.73 | -24.6 | -22.62 | -4.72 | -3.51 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.82 | -0.11 | -7.08 | 2.42 | -1.2 | - | Upgrade
|
| EBT Excluding Unusual Items | -151.33 | 33.43 | -221 | -610.08 | -550.4 | -405.78 | Upgrade
|
| Other Unusual Items | - | - | -46.3 | - | -20.18 | - | Upgrade
|
| Pretax Income | -151.33 | 33.43 | -267.3 | -610.08 | -570.58 | -405.78 | Upgrade
|
| Income Tax Expense | 9.33 | 7.31 | 3.29 | -0.52 | 0.85 | 1.05 | Upgrade
|
| Earnings From Continuing Ops. | -160.66 | 26.12 | -270.59 | -609.55 | -571.43 | -406.83 | Upgrade
|
| Minority Interest in Earnings | -0.58 | -0.69 | -0.13 | 3.28 | -1.18 | - | Upgrade
|
| Net Income | -161.23 | 25.43 | -270.73 | -606.28 | -572.61 | -406.83 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 7.42 | Upgrade
|
| Net Income to Common | -161.23 | 25.43 | -270.73 | -606.28 | -572.61 | -414.24 | Upgrade
|
| Shares Outstanding (Basic) | 250 | 240 | 222 | 212 | 179 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 250 | 266 | 222 | 212 | 179 | 29 | Upgrade
|
| Shares Change (YoY) | -4.81% | 19.94% | 4.32% | 18.72% | 511.57% | 1.56% | Upgrade
|
| EPS (Basic) | -0.65 | 0.11 | -1.22 | -2.85 | -3.20 | -14.16 | Upgrade
|
| EPS (Diluted) | -0.69 | 0.10 | -1.22 | -2.85 | -3.20 | -14.16 | Upgrade
|
| Free Cash Flow | 1,202 | 950.3 | -297.74 | 351.34 | -207.63 | 208.71 | Upgrade
|
| Free Cash Flow Per Share | 4.82 | 3.58 | -1.34 | 1.65 | -1.16 | 7.13 | Upgrade
|
| Operating Margin | -1.21% | 0.62% | -3.23% | -14.88% | -28.75% | -102.89% | Upgrade
|
| Profit Margin | -1.50% | 0.28% | -4.62% | -15.30% | -30.23% | -105.95% | Upgrade
|
| Free Cash Flow Margin | 11.20% | 10.36% | -5.08% | 8.86% | -10.96% | 53.38% | Upgrade
|
| EBITDA | -99.03 | 89.41 | -158.62 | -574.58 | -529.88 | -390.98 | Upgrade
|
| EBITDA Margin | -0.92% | 0.97% | -2.71% | -14.50% | -27.98% | -100.00% | Upgrade
|
| D&A For EBITDA | 30.43 | 32.15 | 30.69 | 15.28 | 14.61 | 11.29 | Upgrade
|
| EBIT | -129.47 | 57.27 | -189.32 | -589.87 | -544.48 | -402.27 | Upgrade
|
| EBIT Margin | -1.21% | 0.62% | -3.23% | -14.88% | -28.75% | -102.89% | Upgrade
|
| Effective Tax Rate | - | 21.85% | - | - | - | - | Upgrade
|
Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.